Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13272 |
UT-155
|
Androgen Receptor | Endocrinology/Hormones |
UT-155 是雄激素受体选择性拮抗剂,能够与 AR-LBD 结合(Ki:267 nM)。 | |||
T5171 |
Treprostinil Sodium
曲前列尼尔钠,UT-15 |
VEGFR; c-RET; Prostaglandin Receptor | Angiogenesis; Apoptosis; GPCR/G Protein; Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Treprostinil Sodium (UT-15) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T13273 |
UT-34
|
Androgen Receptor | Endocrinology/Hormones |
UT-34 是选择性的、具有口服活性的泛雄激素受体拮抗剂和降解剂,能够作用于野生型 AR (IC50:211.7 nM)、F876L-AR (IC50:262.4 nM)、W741L-AR (IC50:215.7 nM)。它与配体结合结构域和功能 1结构域结合,并需要泛素蛋白酶体途径来降解AR。它有抗前列腺癌的能力。 | |||
T23323 | SB 611812 | Neurotensin Receptor | GPCR/G Protein |
SB 611812 是 urotensin-II (UT) 的拮抗剂,可用于心血管疾病治疗的研究。 | |||
T5150 |
Treprostinil
LRX-15,曲前列环素,Orenitram,曲前列尼尔,Remodulin |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil (Orenitram) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T2058 |
Palosuran
ACT-058362 |
GPR | Endocrinology/Hormones; GPCR/G Protein |
Palosuran (ACT-058362) 是人类 UT 受体的新型强效特异性拮抗剂,对表达人重组受体的 CHO 细胞膜的IC50值为 3.6 nM。它可改善糖尿病大鼠的胰腺和肾脏功能。 | |||
TP1928L1 |
[Orn5]-URP acetate
[Orn5]-URP acetate(782485-03-4 free base) |
GPR | Endocrinology/Hormones; GPCR/G Protein |
[Orn5]-URP acetate 是一种有效的选择性 Urotensin-II receptor (UT) 拮抗剂 (pEC50 = 7.24)。 [Orn5]-URP 没有激动剂活性。 | |||
T22476 | (±)-AC 7954 hydrochloride | Neurotensin Receptor | GPCR/G Protein |
(±)-AC 7954 hydrochloride是一种urotensin-II (UT)受体激活剂。 | |||
TP2104L |
UFP 803 acetate
|
Neurotensin Receptor | GPCR/G Protein |
UFP 803 acetate 是一种有效的 urotensin-II (UT) 受体配体。 UFP-803 显示较低残留激动剂的活性。 | |||
T4689 |
Palosuran hydrochloride 540769-28-6(free base)
ACT-058362 hydrochloride |
GPR | Endocrinology/Hormones; GPCR/G Protein |
Palosuran hydrochloride 540769-28-6(free base) (ACT-058362 hydrochloride) 是一种新型强效特异性人 UT 受体拮抗剂,IC50 为 3.6±0.2 nM。 | |||
T12848 |
SB-657510
|
Others; Neurotensin Receptor | GPCR/G Protein; Others |
SB-657510 是 urotensin II (UII) receptor (UT) 拮抗剂。 对于人,猴,猫,大鼠和小鼠的UT 的 Ki 值分别为 61、17、30、65 和 56 nM。SB-657510 通过抑制 UII 诱导的人类血管内皮细胞中炎性介质,如粘附分子,使细胞因子和组织因子上调从而发挥抗炎作用。SB 657510对糖尿病小鼠模型中糖尿病相关动脉粥样硬化疾病具有治疗作用。 | |||
TP2106L |
Urantide acetate(669089-53-6 free base)
|
Neurotensin Receptor | GPCR/G Protein |
Urantide acetate(669089-53-6 free base) 是一种选择性和竞争性的 urotensin-II (UT) 受体拮抗剂 (pKB = 8.3)。体外阻断 hU-II 诱导的胸主动脉收缩。对去甲肾上腺素或内皮素 1 诱导的收缩或乙酰胆碱诱导的松弛没有影响。在钙动员测定(在表达 hUT 受体的 CHO 细胞中)中表现为部分激动剂。 | |||
T37527L |
[Orn8]-Urotensin II acetate
|
GPR | Endocrinology/Hormones; GPCR/G Protein |
[Orn8]-Urotensin II acetate 是一种 Urotensin 受体配体和 Urotensin 受体的部分激动剂。 | |||
T23326 | SB 706375 | Others | Others |
urotensin-II (UT) receptor antagonist | |||
T22815 |
GSK 1562590 hydrochloride
|
Others | Others |
urotensin II (UT) receptor antagonist | |||
T13977 | (R)-UT-155 | Epigenetic Reader Domain | Chromatin/Epigenetic |
(R)-UT-155 is a selective androgen receptor degrader (SARD) ligand. | |||
T75827 |
UFP-803 TFA
|
||
UFP-803 TFA 是有效的urotensin-II receptor (UT)配体。UFP-803 TFA 具有较低的残留激动剂活性,因此它可以作为研究UT 系统在生理学和病理学中作用的重要工具。 | |||
T75828 |
[Orn5]-URP TFA
|
||
[Orn5]-URP TFA 为Urotensin-II receptor (UT) 的有效且选择性纯拮抗剂,具pEC50值7.24,未呈现激动剂活性。 | |||
TP1928 |
[Orn5]-URP
|
||
Urotensin-II (UT) receptor pure antagonist (pEC50 = 7.24). Displays no agonist activity unlike other U-II/URP analogs. Inhibits the action of U-II in the rat aorta ring assay. | |||
TP2106 |
Urantide
|
||
Selective and competitive urotensin-II (UT) receptor antagonist (pKB = 8.3). Blocks hU-II induced contractions in thoracic aorta ex vivo. Exhibits no effect on noradrenaline or endothelin 1-induced contraction or on acetylcholine-induced relaxation. Behav | |||
T36729 |
Urotensin II (goby) (trifluoroacetate salt)
|
||
Urotensin II is a peptide vasoconstrictor and agonist of the urotensin (UT) receptor (Ki= 2.06 nM for the human recombinant receptor expressed in HEK293 cells).1It stimulates intracellular calcium mobilization in HEK293 cells expressing human and rat UT (EC50s = 0.47 and 0.78 nM, respectively) but decreases intracellular calcium concentration in goby (G. mirabilis) enterocytes when used at a concentration of 500 nM.2Urotensin II (20 mU/ml) stimulates active sodium and chloride absorption across ... | |||
TP2104 |
UFP-803
UFP 803 |
||
Urotensin-II (UT) receptor ligand; behaves as a silent antagonist in most in vitro assays and in vivo, but does retain small residual agonist activity under certain conditions in some assays. Competitively antagonizes U-II induced contractions in the rat |